ACRV Acrivon Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACRV

Price (delayed)

$2.075

Market cap

$88.92M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.88

Enterprise value

$49.42M

?
Relative Growth: Rel. Growth: 9
Relative Strength: Rel. Strength: 84
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 8
Highlights
Acrivon Therapeutics's debt has decreased by 35% YoY and by 12% QoQ
The EPS has grown by 16% YoY and by 6% from the previous quarter
ACRV's equity is down by 39% YoY and by 9% QoQ
ACRV's quick ratio is down by 23% YoY and by 11% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.acrivon.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of ACRV

ACRV stock price

How has the Acrivon Therapeutics stock price performed over time
Intraday
-3.49%
1 week
-3.49%
1 month
33.01%
1 year
54.85%
YTD
-13.9%
QTD
16.57%

Financial performance

How have Acrivon Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$78.37M
Net income
-$74.23M
Gross margin
N/A
Net margin
N/A
The operating income has increased by 17% year-on-year and by 4.8% since the previous quarter
ACRV's net income is up by 14% year-on-year and by 3.9% since the previous quarter

Price vs fundamentals

How does ACRV's price correlate with its fundamentals

Growth

What is Acrivon Therapeutics's growth rate over time

Valuation

What is Acrivon Therapeutics stock price valuation
P/E
N/A
P/B
1.02
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 16% YoY and by 6% from the previous quarter
The P/B is 77% above the last 4 quarters average of 0.6
ACRV's equity is down by 39% YoY and by 9% QoQ

Efficiency

How efficient is Acrivon Therapeutics business performance
The ROIC has plunged by 62% YoY and by 16% from the previous quarter
Acrivon Therapeutics's return on equity has decreased by 38% YoY and by 9% QoQ
The ROA has contracted by 34% YoY and by 8% from the previous quarter

Dividends

What is ACRV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACRV.

Financial health

How did Acrivon Therapeutics financials performed over time
The total assets is down by 38% year-on-year and by 8% since the previous quarter
ACRV's quick ratio is down by 23% YoY and by 11% from the previous quarter
Acrivon Therapeutics's debt is 98% lower than its equity
ACRV's equity is down by 39% YoY and by 9% QoQ
Acrivon Therapeutics's debt has decreased by 35% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.